How Can Oncogenic RNAs be Targeted for Cancer Therapy?
Targeting oncogenic RNAs offers a promising approach for cancer therapy. Techniques such as [antisense oligonucleotides](https://) (ASOs) and small interfering RNAs (siRNAs) can be designed to specifically degrade or inhibit the function of oncogenic RNAs. Additionally, [CRISPR/Cas9](https://) technology can be employed to edit or disrupt the genes encoding these RNAs. These strategies aim to restore normal gene expression patterns and inhibit tumor growth.
